Simvastatin tablets

DRUG3 trials

Sponsors

Federico II University, CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Helsinki University Central Hospital

Conditions

Drug InteractionHealthy SubjectsPostprandial LipemiaType 2 Diabetes

Phase 1

A Study to Evaluate the DDI of DBPR108 With Metformin,Glibenclamide,Valsartan, or Simvastatin in Healthy Subjects

CompletedNCT04859452

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Healthy Subjects

Start: 2021-05-26End: 2021-07-09Updated: 2021-07-20

Phase 4

Ezetimibe and Statins on Postprandial Lipemia in Type 2 Diabetes

CompletedNCT00699023

Federico II UniversityPostprandial Lipemia, Type 2 Diabetes

Start: 2008-06-30End: 2009-10-31Target: 13Updated: 2009-11-04

Unknown Phase

KF2022#4-trial: Effects of a Beta Blocker and NSAID on CYP Mediated Drug Metabolism

CompletedNCT06566794

Helsinki University Central HospitalDrug Interaction

Start: 2024-08-22End: 2025-01-10Updated: 2026-03-06

Related Papers

Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes.

2011-03-1550 citations